Insights Care Magazine: Most Influential COOs in the Healthcare Industry to Follow—Altasciences' Marie-Hélène Raigneau
Discover Altasciences’ Clinical Trial Site Solutions
Altasciences' Clinical Trial Site Solutions provides a strategic advantage for your projects.
Benefit from:
- Diverse Patient Populations: Access our global network of specialized sites for challenging research projects.
- Expert Site Identification and Oversight: Leverage our high-recruitment partner sites, historical data, and dedicated project managers for efficient trial management.
- Tailored Support: Reduce potential challenges with our comprehensive site evaluation, which includes experienced physicians in your target therapeutic area able to provide valuable feedback on protocol design.
- Streamlined Operations: Experience expedited site selection, budget negotiations, and investigator grant payments.
Ready to discover the advantages of Altasciences' Clinical Trial Site Solutions?
Four Pain Models Altasciences Uses to Assess Treatments During Clinical Trials
September is pain awareness month, and the importance of pain management and continued research into effective analgesics is integral to helping patients suffering from various pain conditions.
Critical Considerations for the Manufacture of Highly Potent Compounds
The demand for highly potent active pharmaceutical ingredients (HPAPIs) has been increasing over the past decade, mainly driven by oncology research.
In this issue, we examine the intricacies of manufacturing HPAPIs and associated drug products, including a review of the relevant guidance, classification systems, and safety processes. We also explore how CDMO facilities, equipment, and procedures for HPAPIs should be adapted to ensure safety, compliance with GMP regulations, and the successful manufacture of your product.
READ THE ISSUE
Related resources that may interest you:
Webpage: High Potency Manufacturing Services
Webinar: Nanosuspension Formulations for Poorly Soluble Drugs
Interview: Handling Your Highly Potent APIs and Controlled Substances
Manufacturing With a Highly Potent API for an Ophthalmic Indication